IP Library Patent Application 17563234
Patent Application
App. No. 17/563,234

TRANSDERMAL DRUG DELIVERY APPARATUS AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/563,234
Abstract

A transdermal drug delivery apparatus includes a housing for being fastened to a user, a microneedle assembly for being engaged against the skin of the user, a first force provider for providing a first force for forcing the microneedle assembly outwardly from the housing and against the skin, a reservoir movably carried by the housing for containing the fluid and for being in fluid communication with the microneedle assembly, and a second force provider for providing a second force for causing at least some of the fluid to flow from the reservoir to the microneedle assembly after the reservoir has moved into fluid communication with the microneedle assembly.

Claims (30)

1 - 53 . (canceled)

54 . A method of at least partially using a transdermal drug delivery apparatus, the method comprising:

fastening the transdermal drug delivery apparatus to a user;

engaging a microneedle assembly of the apparatus against skin of the user so that a first force provider of the apparatus forces the microneedle assembly against the skin; and

while the apparatus is fastened to the user and the first force provider is forcing the microneedle assembly against the skin, causing a second force provider of the apparatus to at least indirectly force fluid to flow from a reservoir of the apparatus to the microneedle assembly.

55 . The method according to claim 54 , wherein the engaging of the microneedle assembly of the apparatus against the skin is comprised of compressing the first force provider.

56 . The method according to claim 54 , wherein the engaging of the microneedle assembly against the skin occurs prior to the fastening of the apparatus to the user.

57 . The method according to claim 54 , further comprising moving the reservoir into fluid communication with the microneedle assembly, wherein the causing of the second force provider to at least indirectly force the fluid to flow is at least partially responsive to the moving of the reservoir into fluid communication with the microneedle assembly.

58 . The method according to claim 54 , wherein:

the first force provider comprises at least one spring; and

the first force provider forcing the microneedle assembly against the skin is comprised of the at least one spring being compressed and forcing the microneedle assembly against the skin.

59 . The method according to claim 58 , wherein:

the second force provider comprises a second spring; and

the causing of the second force provider of the apparatus to at least indirectly force the fluid to flow is comprised of the second spring expanding.

60 . The method according to claim 54 , wherein the causing of the second force provider of the apparatus to at least indirectly force the fluid to flow from the reservoir is comprised of pushing a pushbutton of the apparatus.

61 . The method according to claim 60 , wherein the pushing of the pushbutton moves the reservoir into fluid communication with the microneedle assembly.

62 . The method according to claim 54 , wherein the second force provider at least indirectly forcing fluid to flow from the reservoir is comprised of the reservoir being at least partially collapsed.

63 . The method according to claim 62 , wherein the second force provider at least indirectly forcing fluid to flow from the reservoir is comprised of force from at least one expanding spring urging a pushing mechanism against the reservoir.

64 . A method of using a transdermal drug delivery apparatus, the method comprising:

engaging a microneedle assembly of the apparatus against skin of a user, comprising causing relative movement between a housing of the apparatus and the user; and

then moving a reservoir of the apparatus into fluid communication with the microneedle assembly, comprising moving the reservoir relative to both the housing and the microneedle assembly, wherein

the moving of the reservoir is comprised of pushing a portion of the apparatus that is for moving the reservoir,

the pushing of the portion is comprised of pushing the portion with sufficient force so that at least one connector of the apparatus at least partially releases the portion from the housing in response to the pushing, and

the moving of the reservoir is responsive to the at least one connector of the apparatus at least partially releasing the portion from the housing.

65 . The method according to claim 64 , wherein the portion of the apparatus comprises a pushbutton.

66 . The method according to claim 64 , wherein the at least one connector is a snap-fit connector.

67 . The method according to claim 64 , wherein:

the at least one connector is at least one first connector that comprises a connector part;

the method further comprises the moving of the reservoir being arrested by at least one second connector of the apparatus transitioning from an unconnecting state to a connecting state; and

the at least one second connector also comprises the connector part.

Assignments (12)
CHANGE OF NAME Recorded Nov 3, 2025
From: VIVASOR SUB 4 LLC
To: SOFUSA HOLDINGS LLC
Reel/Frame 073484/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2025
From: VIVASOR, INC.
To: VIVASOR SUB 4 LLC
Reel/Frame 073362/0156 →
SECURITY INTEREST Recorded Apr 21, 2025
From: VIVASOR, INC.
To: PROCOPIO, CORY, HARGREAVES & SAVITCH LLP
Reel/Frame 070896/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2024
From: SORRENTO THERAPEUTICS, INC.
To: VIVASOR, INC.
Reel/Frame 067413/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Sep 21, 2023
From: SCILEX HOLDING COMPANY
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 065017/0844 →
RELEASE OF SECURITY INTEREST Recorded Aug 11, 2023
From: JMB CAPITAL PARTNERS LENDING, LLC
To: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
Reel/Frame 064571/0848 →
SECURITY INTEREST Recorded Jul 31, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: SCILEX HOLDING COMPANY
Reel/Frame 064441/0575 →
SECURITY INTEREST Recorded Apr 6, 2023
From: SORRENTO THERAPEUTICS, INC.; SCINTILLA PHARMACEUTICALS, INC.
To: JMB CAPITAL PARTNERS LENDING, LLC
Reel/Frame 063283/0063 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: SORRENTO THERAPEUTICS, INC.
Reel/Frame 058488/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: XIMEDICA, LLC
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 058488/0066 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: HAGAN, LUKE
To: XIMEDICA LLC
Reel/Frame 058488/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: BAKER, ANDREW T.; ROSS, RUSSELL F.; GADSBY, ELIZABETH DEIBLER
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 058488/0001 →